knockdown KNSTRN 破坏了自流,以抑制膀癌的进展
Xianbin Huang1, Yanqiu Meng2, Jielong Song1
1Department of Oncology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, China.
iScience
|February 18, 2026
概括
基内托科尔局部化素结合蛋白 (KNSTRN) 倒退通过破坏自抑制膀癌 (BLCA). 这通过反应性氧物种 (ROS) 发生,这些物种损害了 lysosomal 功能,阻断了自菌体-lysosome 融合.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 分子机制的分子机制
背景情况:
- 膀癌 (BLCA) 是一种普遍存在的尿道系统恶性瘤.
- 基内托科尔局部化素结合蛋白 (KNSTRN) 与各种癌症发展有关.
- 失调的自显著影响瘤的进展.
研究的目的:
- 阐明KNSTRN调节BLCA中自的机制.
- 调查KNSTRN在BLCA进展和自流动中的作用.
主要方法:
- 研究了KNSTRN对BLCA细胞中自流的淘汰效应.
- 评估了活性氧物种 (ROS) 和溶酶体功能的作用.
- 使用克里奥基诺来恢复 lysosomal 活动和 N-乙半氨酸 (NAC) 作为 ROS 清理器.
- 在体外和体内使用拉巴胺素 (Rapa) 作为自激活剂.
主要成果:
- 在BLCA中,KNSTRN knockdown显著抑制了自流.
- 在KNSTRN敲除后观察到ROS积累和溶酶体功能障碍,阻碍了自细胞-溶酶体融合.
- 克里奥基诺和NAC治疗逆转了溶酶体功能障碍,并恢复了自流.
- 拉帕米辛在体外和体内抵消了KNSTRN knockdown诱导的细胞死亡.
结论:
- 通过诱导ROS和 lysosomal 功能障碍,KNSTRN 淘汰破坏了 BLCA 的进展,从而抑制了自流.
- 向ROS和恢复 lysosomal 功能为BLCA提供了一个潜在的治疗策略.
相关概念视频
01:31The Intrinsic Apoptotic Pathway
8.8K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
8.8K
03:03mTOR Signaling and Cancer Progression
4.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.9K
02:34Inhibition of Cdk Activity
6.1K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K